Independent reference. No email capture, no upsell, no demo. Not affiliated with any data provider mentioned.
Terminal Value CalculatorDCF / Gordon Growth / Exit Multiple
Use case

Equity Research Terminal Value

Sell-side equity research typically uses a two-stage DCF with Gordon Growth at the seam, then reconciles the implied target price to relative-valuation multiples for cross-check.

Direct answer
Equity research terminal value is almost always a Gordon Growth-at-the-seam two-stage DCF. The explicit period runs five to ten years; the perpetuity growth rate sits near long-run nominal GDP for the relevant economy; the discount rate is the firm's WACC. The output target price is then cross-checked against EV/EBITDA, P/E, and EV/Sales relative-valuation grids.
Conventions

What sell-side research models tend to do

Explicit period: 5 to 10 years

Long enough to capture margin expansion or contraction stories. Short enough that the explicit-period cash flows are recognisably the same business as today. Longer windows shift weight to the explicit forecast and away from terminal value.

Perpetuity g: long-run nominal GDP

2 to 3 percent for the United States; 1.5 to 2.5 percent for the eurozone; higher for emerging-market economies per IMF WEO long-horizon projections. Above 4 percent and the analyst should explain.

WACC: industry-anchored

Equity research desks typically anchor WACC to the Damodaran industry benchmark and then adjust for company- specific leverage. A WACC that drifts more than 100bps from the industry benchmark needs justification.

Target-price sensitivity table

Almost every published model ships a g-vs-WACC table showing target price across the corners. The reader's first move is to find the analyst's central estimate and evaluate the corners.

The cross-check

Reconcile DCF target to relative-valuation grid

A DCF target price that implies an EV/EBITDA materially above the peer-group range tells the reader the DCF is doing too much of the work. Best practice is to show DCF target alongside relative-valuation target across two or three multiples (EV/ EBITDA, EV/Sales, P/E forward) and a sum-of-parts table where relevant.

Last verified June 2026. Source: Damodaran Investment Valuation 3rd ed.; Koller Valuation 7th ed.